TBX21	O
:	O
a	O
functional	O
variant	O
predicts	O
improvement	O
in	O
asthma	O
with	O
the	O
use	O
of	O
inhaled	O
corticosteroids	O
.	O

TBX21	O
encodes	O
for	O
the	O
transcription	O
factor	O
T	O
-	O
bet	O
(	O
T	O
-	O
box	O
expressed	O
in	O
T	B-Cell
cells	I-Cell
)	O
,	O
which	O
influences	O
naive	O
T	B-Cell
lymphocyte	I-Cell
development	O
and	O
has	O
been	O
implicated	O
in	O
asthma	O
pathogenesis	O
.	O

Specifically	O
,	O
the	O
T	O
-	O
bet	O
knockout	O
mouse	O
spontaneously	O
develops	O
airway	B-Multi-tissue_structure
hyperresponsiveness	O
and	O
other	O
changes	O
consistent	O
with	O
asthma	O
.	O

Because	O
airway	B-Multi-tissue_structure
responsiveness	O
is	O
moderated	O
by	O
the	O
use	O
of	O
inhaled	O
corticosteroids	O
in	O
asthma	O
,	O
it	O
is	O
conceivable	O
that	O
genetic	O
variation	O
in	O
TBX21	O
may	O
alter	O
asthma	O
phenotypes	O
in	O
a	O
treatment	O
-	O
specific	O
fashion	O
.	O

Here	O
we	O
demonstrate	O
that	O
the	O
nonsynonymous	O
variation	O
in	O
TBX21	O
coding	O
for	O
replacement	O
of	O
histidine	O
33	O
with	O
glutamine	O
is	O
associated	O
with	O
significant	O
improvement	O
in	O
the	O
PC	O
(	O
20	O
)	O
(	O
a	O
measure	O
of	O
airway	B-Multi-tissue_structure
responsiveness	O
)	O
of	O
asthmatic	O
children	O
in	O
a	O
large	O
clinical	O
trial	O
spanning	O
4	O
years	O
.	O

We	O
note	O
that	O
this	O
increase	O
occurs	O
only	O
in	O
the	O
children	O
randomized	O
to	O
inhaled	O
corticosteroids	O
and	O
that	O
it	O
dramatically	O
enhances	O
the	O
overall	O
improvement	O
in	O
PC	O
(	O
20	O
)	O
associated	O
with	O
inhaled	O
corticosteroid	O
usage	O
.	O

The	O
average	O
PC	O
(	O
20	O
)	O
at	O
trial	O
end	O
for	O
subjects	O
on	O
inhaled	O
corticosteroids	O
possessing	O
a	O
variant	O
allele	O
was	O
in	O
the	O
normal	O
range	O
for	O
nonasthmatics	O
.	O

In	O
cellular	B-Cell
models	O
,	O
we	O
show	O
that	O
the	O
TBX21	O
variant	O
increases	O
T	B-Cell
helper	I-Cell
1	I-Cell
and	O
decreases	O
T	B-Cell
helper	I-Cell
2	I-Cell
cytokine	O
expression	O
comparably	O
with	O
wild	O
type	O
.	O

TBX21	O
may	O
thus	O
be	O
an	O
important	O
determinant	O
pharmacogenetic	O
response	O
to	O
the	O
therapy	O
of	O
asthma	O
with	O
inhaled	O
corticosteroids	O
.	O

